Exploring environmental modifiers of LRRK2-associated Parkinson's disease penetrance: An exposomics and metagenomics pilot study on household dust

被引:0
|
作者
Andujar, Begona Talavera [1 ]
Pereira, Sandro L. [1 ]
Busi, Susheel Bhanu [1 ,2 ]
Usnich, Tatiana [3 ]
Borsche, Max [3 ,4 ]
Ertan, Sibel [5 ]
Bauer, Peter [6 ]
Rolfs, Arndt [6 ]
Hezzaz, Soraya [1 ]
Ghelfi, Jenny [1 ]
Brueggemann, Norbert [3 ,4 ]
Antony, Paul [1 ]
Wilmes, Paul [1 ,7 ]
Klein, Christine [3 ]
Gruenewald, Anne [1 ]
Schymanski, Emma L. [1 ]
机构
[1] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, L-4367 Belvaux, Luxembourg
[2] UK Ctr Ecol & Hydrol, Wallingford, Oxon, England
[3] Univ Lubeck, Inst Neurogenet, Lubeck, Germany
[4] Univ Lubeck, Dept Neurol, Lubeck, Germany
[5] Koc Univ, Sch Med, Dept Neurol, Istanbul, Turkiye
[6] CENTOGENE GmbH, Rostock, Germany
[7] Univ Luxembourg, Fac Sci Technol & Med, Dept Life Sci & Med, L-4362 Esch Sur Alzette, Luxembourg
关键词
Indoor environment; Exposomics; Metagenomics; Parkinson's disease; Leucine-rich repeat kinase 2 (LRRK2); Bisphenol S; MASS-SPECTROMETRY; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; PIPECOLIC ACID; IN-VITRO; MANAGEMENT; RELEVANCE; FIPRONIL; BACTERIA;
D O I
10.1016/j.envint.2024.109151
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Pathogenic variants in the Leucine-rich repeat kinase 2 (LRRK2) gene are a primary monogenic cause of Parkinson's disease (PD). However, the likelihood of developing PD with inherited LRRK2 pathogenic variants differs (a phenomenon known as "reduced penetrance"), with factors including age and geographic region, highlighting a potential role for lifestyle and environmental factors in disease onset. To investigate this, household dust samples from four different groups of individuals were analyzed using metabolomics/exposomics and metagenomics approaches: PD+/LRRK2+ (PD patients with pathogenic LRRK2 variants; n = 11), PD-/LRRK2+ (individuals with pathogenic LRRK2 variants but without PD diagnosis; n = 8), iPD (PD of unknown cause; n = 11), and a matched, healthy control group (n = 11). The dust was complemented with metabolomics and lipidomics of matched serum samples, where available. A total of 1,003 chemicals and 163 metagenomic operational taxonomic units (mOTUs) were identified in the dust samples, of which ninety chemicals and ten mOTUs were statistically significant (ANOVA p-value < 0.05). Reduced levels of 2-benzothiazolesulfonic acid (BThSO3) were found in the PD-/LRRK2+ group compared to the PD+/LRRK2+ . Among the significant chemicals tentatively identified in dust, two are hazardous chemical replacements: Bisphenol S (BPS), and perfluorobutane sulfonic acid (PFBuS). Furthermore, various lipids were found altered in serum including different lysophosphatidylethanolamines (LPEs), and lysophosphatidylcholines (LPCs), some with higher levels in the PD+/LRRK2+ group compared to the control group. A cellular study on isogenic neurons generated from a PD+/LRRK2+ patient demonstrated that BPS negatively impacts mitochondrial function, which is implicated in PD pathogenesis. This pilot study demonstrates how non-target metabolomics/exposomics analysis of indoor dust samples complemented with metagenomics can prioritize relevant chemicals that may be potential modifiers of LRRK2 penetrance.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] The role of genetic modifiers in Parkinson's disease-associated LRRK2-G2019S mutation
    Courtin, T.
    Ianello, G.
    Bertrand, H.
    Benromdhan, S.
    Tesson, C.
    Mhiri, C.
    Corvol, J. C.
    Lesage, S.
    Brice, A.
    MOVEMENT DISORDERS, 2019, 34 : S172 - S173
  • [42] Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab-Berbers
    Follett, Jordan
    Guenther, Dylan
    Xoi, Leyna
    Amouri, Rim
    Ben Sassi, Samia
    Hentati, Faycel
    Farrer, Matthew J.
    MOVEMENT DISORDERS, 2024, 39 (04) : 751 - 753
  • [43] Exploring Mitochondrial Mechanisms Defining Parkinson's Disease Penetrance in LRRK2 G2019S Neuronal Cultures
    Delcambre, S.
    Ghelfi, J.
    Hezzaz, S.
    Klein, C.
    Trinh, J.
    Seibler, P.
    Antony, P.
    Pereira, S.
    Grunewald, A.
    MOVEMENT DISORDERS, 2023, 38 : S641 - S641
  • [44] Comparing Rates of Motor Progression before and after DBS among Patients with Idiopathic and LRRK2-Associated Parkinson's Disease
    Viser, Aaron C.
    Leaver, Katherine
    Miravite, Joan
    Kopell, Brian H.
    Ortega, Robert
    Raymond, Deborah
    Bressman, Susan B.
    Saunders-Pullman, Rachel
    San Luciano, Marta
    ANNALS OF NEUROLOGY, 2020, 88 : S181 - S181
  • [45] Environmental Factors are Associated with Disease Severity of LRRK2 Related Parkinson's disease (PD) and Idiopathic Parkinson's disease (PD) : a Longitudinal Study
    Lueth, T.
    Caliebe, A.
    Gabbert, C.
    Koch, S.
    Laabs, B. -H.
    Koenig, I. R.
    Klein, C.
    Trinh, J.
    MOVEMENT DISORDERS, 2024, 39 : S216 - S216
  • [46] Analysis of retinal nerve layers in idiopathic, LRRK2-associated Parkinson's disease and unaffected carriers of G2019S mutation
    Cervero, Andrea
    Sanchez-Rodriguez, Antonio
    Rivera-Sanchez, Maria
    Martinez-Rodriguez, Isabel
    Sierra, Maria
    Gonzalez-Aramburu, Isabel
    Gutierrez-Gonzalez, Angela
    Andres-Pacheco, Javier
    Sanchez-Pelaez, Maria Victoria
    Casado, Alfonso
    Infante, Jon
    PARKINSONISM & RELATED DISORDERS, 2023, 106
  • [47] Nonsteroidal Anti-Inflammatory Use and LRRK2 Parkinson's Disease Penetrance
    San Luciano, Marta
    Tanner, Caroline M.
    Meng, Cheryl
    Marras, Connie
    Goldman, Samuel M.
    Lang, Anthony E.
    Tolosa, Eduardo
    Schule, Birgitt
    Langston, J. William
    Brice, Alexis
    Corvol, Jean-Christophe
    Goldwurm, Stefano
    Klein, Christine
    Brockman, Simone
    Berg, Daniela
    Brockmann, Kathrin
    Ferreira, Joachim J.
    Tazir, Meriem
    Mellick, George D.
    Sue, Carolyn M.
    Hasegawa, Kazuko
    Tan, Eng King
    Bressman, Susan
    Saunders-Pullman, Rachel
    MOVEMENT DISORDERS, 2020, 35 (10) : 1755 - 1764
  • [48] Lack of central and peripheral nervous system synuclein pathology in R1441G LRRK2-associated Parkinson's disease
    Vilas, Dolores
    Gelpi, Ellen
    Aldecoa, Iban
    Grau, Oriol
    Rodriguez-Diehl, Roberta
    Jauma, Serge
    Jose Marti, Maria
    Tolosa, Eduard
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (07): : 832 - +
  • [49] LRRK2 Ashkenazi Jewish Consortium. Progression in the LRRK2-associated Parkinson disease population (vol 75, pg 312, 2018)
    Saunders-Pullman, R.
    Mirelman, A.
    Alcalay, R. N.
    JAMA NEUROLOGY, 2018, 75 (06) : 763 - 763
  • [50] Kin-Cohort Analysis of LRRK2-G2019S Penetrance in Parkinson's Disease
    Goldwurm, Stefano
    Tunesi, Sara
    Tesei, Silvana
    Zini, Michela
    Sironi, Francesca
    Primignani, Paola
    Magnani, Corrado
    Pezzoli, Gianni
    MOVEMENT DISORDERS, 2011, 26 (11) : 2144 - 2145